Paul Heffernan - Myndai, Executive Operations
| MYND Stock | USD 2.31 0.52 29.05% |
Executive
Paul Heffernan is Executive Operations of Myndai,
| Age | 55 |
| Address | , Cayman Islands |
| Phone | 86 10 8767 5611 |
| Web | https://www.mynd.ai |
Myndai, Management Efficiency
The company has return on total asset (ROA) of (0.0723) % which means that it has lost $0.0723 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3561) %, meaning that it created substantial loss on money invested by shareholders. Myndai,'s management efficiency ratios could be used to measure how well Myndai, manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.12. The current year's Return On Capital Employed is expected to grow to -0.18. At present, Myndai,'s Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 54 M, whereas Non Current Assets Total are forecasted to decline to about 159.5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Christopher LLB | Agnico Eagle Mines | N/A | |
| Mohammed Ali | Agnico Eagle Mines | N/A | |
| Sherry Siu | East Africa Metals | 55 | |
| Trent Musso | Summit Materials | N/A | |
| Mike Vannoy | Asure Software | N/A | |
| Craig Hazenfield | Definitive Healthcare Corp | N/A | |
| Patricia Wadors | ServiceNow | 54 | |
| Michael Drory | CDW Corp | N/A | |
| Colin Fleming | ServiceNow | N/A | |
| Matthew Ruderman | Definitive Healthcare Corp | N/A | |
| Steven OBrien | CDW Corp | N/A | |
| John Castelly | ServiceNow | N/A | |
| BSc Eng | Agnico Eagle Mines | N/A | |
| Jason Allaire | Agnico Eagle Mines | N/A | |
| Julio DaSilva | Summit Materials | N/A | |
| Aletha Noonan | CDW Corp | N/A | |
| Chirantan Desai | ServiceNow | 53 | |
| Carrie Lazorchak | Definitive Healthcare Corp | 54 | |
| Charles DePriest | Summit Materials | 51 | |
| Eyal Goldstein | Asure Software | 48 | |
| Richard CPA | Definitive Healthcare Corp | 55 | |
Management Performance
| Return On Equity | -1.36 | ||||
| Return On Asset | -0.0723 |
Myndai, Leadership Team
Elected by the shareholders, the Myndai,'s board of directors comprises two types of representatives: Myndai, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Myndai,. The board's role is to monitor Myndai,'s management team and ensure that shareholders' interests are well served. Myndai,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Myndai,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Siyuan Wang, Chief Officer | ||
| Vincent Riera, CEO Director | ||
| Allyson Krause, Executive Counsel | ||
| Lance Solomon, Chief Officer | ||
| Yanlai Shi, CEO CoFounder | ||
| Ronan OLoan, Chief Officer | ||
| Serena Xue, Manager Relations | ||
| Paul Heffernan, Executive Operations | ||
| Matthew Cole, Executive Sales | ||
| Chimin Cao, CoFounder Chairman | ||
| Arthur Giterman, Chief Officer |
Myndai, Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Myndai, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.36 | ||||
| Return On Asset | -0.0723 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 127.61 M | ||||
| Shares Outstanding | 45.65 M | ||||
| Shares Owned By Institutions | 0.85 % | ||||
| Number Of Shares Shorted | 8.82 K | ||||
| Price To Earning | (1.27) X | ||||
| Price To Book | 1.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Myndai, is a strong investment it is important to analyze Myndai,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Myndai,'s future performance. For an informed investment choice regarding Myndai, Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myndai,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Myndai, Stock refer to our How to Trade Myndai, Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myndai,. If investors know Myndai, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myndai, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 8.06 | Quarterly Revenue Growth (0.25) | Return On Assets (0.07) | Return On Equity (1.36) |
The market value of Myndai, is measured differently than its book value, which is the value of Myndai, that is recorded on the company's balance sheet. Investors also form their own opinion of Myndai,'s value that differs from its market value or its book value, called intrinsic value, which is Myndai,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myndai,'s market value can be influenced by many factors that don't directly affect Myndai,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myndai,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Myndai, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myndai,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.